Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
S. Wu, Q. Sheng, P. Liu, Z. Jiao, J. Lv, R. Qiao, D. Xie, Z. Wang, J. Ge, P. Li, T. Wei, J. Lei, J. Fan, L. Wang
This study develops a model using M1 macrophage-related genes to predict immunotherapy response and prognosis in advanced NSCLC patients.
Acta Biochimica et Biophysica Sinica · Feb 21, 2024Peer-reviewedImmunology
X. Zhao, T. Qiu, X. Huang, Q. Mao, Y. Wang, R. Qiao, T. Mao, Y. Wang, J. Li, C. Luo, C. Yoon, X. Wang, C. Li, Y. Cui, C. Zhao, , P. Wang
This study identifies potent and broadly neutralizing antibodies against SARS-CoV-2 and related sarbecoviruses from a vaccinated donor, showing their efficacy against multiple variants and providing insights for therapeutic development.
Cell Discovery · Feb 6, 2024Peer-reviewedImmunology
X. Wang, S. Jiang, W. Ma, X. Li, K. Wei, F. Xie, C. Zhao, X. Zhao, C. Li, R. Qiao, Y. Cui, Y. Chen, J. Li, G. Cai, C. Liu, , P. Wang
This study evaluates the neutralization efficacy of a tetravalent vaccine booster against emerging SARS-CoV-2 variants, finding it induces higher neutralizing titers than breakthrough infection.
bioRxiv · Sep 14, 2023 · PreprintImmunology
X. Wang, S. Jiang, S. Jiang, X. Li, J. Ai, K. Lin, S. Lv, S. Zhang, M. Li, X. He, D. Li, C. Li, C. Zhao, X. Zhao, R. Qiao, , P. Wang
This study assesses neutralization of SARS-CoV-2 Omicron subvariants by sera from different vaccination and breakthrough infection cohorts, finding that BQ.1.1 and XBB.1.5 show strong neutralization evasion.
bioRxiv · Feb 7, 2023 · PreprintImmunology
X. Wang, J. Ai, X. Li, X. Zhao, J. Wu, H. Zhang, X. He, C. Zhao, R. Qiao, M. Li, Y. Cui, Y. Chen, L. Yang, Z. Hu, C. Xu, , P. Wang
This study evaluates neutralization of Omicron sub-lineages by booster vaccination or BA.2 breakthrough infection sera using a pseudovirus panel.
bioRxiv · Aug 4, 2022Immunology
J. Ai, X. Wang, X. He, X. Zhao, Y. Zhang, Y. Jiang, M. Li, Y. Cui, Y. Chen, R. Qiao, L. Li, L. Yang, Y. Li, Z. Hu, W. Zhang, P. Wang
This study compares antibody neutralization efficacy against SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, BA.2, and BA.3, showing increased resistance and the benefit of vaccine boosters.
bioRxiv · Apr 7, 2022 · PreprintMicrobiology